ID KGD_MYCLE Reviewed; 1238 AA. AC Q9CC97; DT 13-NOV-2007, integrated into UniProtKB/Swiss-Prot. DT 13-NOV-2007, sequence version 2. DT 27-MAR-2024, entry version 120. DE RecName: Full=Multifunctional 2-oxoglutarate metabolism enzyme; DE AltName: Full=2-hydroxy-3-oxoadipate synthase; DE Short=HOA synthase; DE Short=HOAS; DE EC=2.2.1.5; DE AltName: Full=2-oxoglutarate carboxy-lyase; DE AltName: Full=2-oxoglutarate decarboxylase; DE AltName: Full=Alpha-ketoglutarate decarboxylase; DE Short=KG decarboxylase; DE Short=KGD; DE EC=4.1.1.71; DE AltName: Full=Alpha-ketoglutarate-glyoxylate carboligase; DE Includes: DE RecName: Full=2-oxoglutarate dehydrogenase E1 component; DE Short=ODH E1 component; DE EC=1.2.4.2; DE AltName: Full=Alpha-ketoglutarate dehydrogenase E1 component; DE Short=KDH E1 component; DE Includes: DE RecName: Full=Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex; DE EC=2.3.1.61; DE AltName: Full=2-oxoglutarate dehydrogenase complex E2 component; DE Short=ODH E2 component; DE Short=OGDC-E2; DE AltName: Full=Dihydrolipoamide succinyltransferase; GN Name=kgd; OrderedLocusNames=ML1095; OS Mycobacterium leprae (strain TN). OC Bacteria; Actinomycetota; Actinomycetes; Mycobacteriales; Mycobacteriaceae; OC Mycobacterium. OX NCBI_TaxID=272631; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=TN; RX PubMed=11234002; DOI=10.1038/35059006; RA Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., RA Wheeler P.R., Honore N., Garnier T., Churcher C.M., Harris D.E., RA Mungall K.L., Basham D., Brown D., Chillingworth T., Connor R., RA Davies R.M., Devlin K., Duthoy S., Feltwell T., Fraser A., Hamlin N., RA Holroyd S., Hornsby T., Jagels K., Lacroix C., Maclean J., Moule S., RA Murphy L.D., Oliver K., Quail M.A., Rajandream M.A., Rutherford K.M., RA Rutter S., Seeger K., Simon S., Simmonds M., Skelton J., Squares R., RA Squares S., Stevens K., Taylor K., Whitehead S., Woodward J.R., RA Barrell B.G.; RT "Massive gene decay in the leprosy bacillus."; RL Nature 409:1007-1011(2001). CC -!- FUNCTION: Shows three enzymatic activities that share a first common CC step, the attack of thiamine-PP on 2-oxoglutarate (alpha-ketoglutarate, CC KG), leading to the formation of an enamine-thiamine-PP intermediate CC upon decarboxylation. Thus, displays KGD activity, catalyzing the CC decarboxylation from five-carbon 2-oxoglutarate to four-carbon CC succinate semialdehyde (SSA). Also catalyzes C-C bond formation between CC the activated aldehyde formed after decarboxylation of alpha- CC ketoglutarate and the carbonyl of glyoxylate (GLX), to yield 2-hydroxy- CC 3-oxoadipate (HOA), which spontaneously decarboxylates to form 5- CC hydroxylevulinate (HLA). And is also a component of the 2-oxoglutarate CC dehydrogenase (ODH) complex, that catalyzes the overall conversion of CC 2-oxoglutarate to succinyl-CoA and CO(2). The KG decarboxylase and KG CC dehydrogenase reactions provide two alternative, tightly regulated, CC pathways connecting the oxidative and reductive branches of the TCA CC cycle (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxoglutarate + glyoxylate + H(+) = 2-hydroxy-3-oxoadipate + CC CO2; Xref=Rhea:RHEA:14341, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, CC ChEBI:CHEBI:16810, ChEBI:CHEBI:36655, ChEBI:CHEBI:57712; EC=2.2.1.5; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxoglutarate + H(+) = CO2 + succinate semialdehyde; CC Xref=Rhea:RHEA:10524, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, CC ChEBI:CHEBI:16810, ChEBI:CHEBI:57706; EC=4.1.1.71; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxoglutarate + H(+) + N(6)-[(R)-lipoyl]-L-lysyl- CC [dihydrolipoyllysine-residue succinyltransferase] = CO2 + N(6)-[(R)- CC S(8)-succinyldihydrolipoyl]-L-lysyl-[dihydrolipoyllysine-residue CC succinyltransferase]; Xref=Rhea:RHEA:12188, Rhea:RHEA-COMP:10483, CC Rhea:RHEA-COMP:10484, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, CC ChEBI:CHEBI:16810, ChEBI:CHEBI:83099, ChEBI:CHEBI:83120; EC=1.2.4.2; CC -!- CATALYTIC ACTIVITY: CC Reaction=N(6)-[(R)-dihydrolipoyl]-L-lysyl-[2-oxoglutarate dehydrogenase CC complex component E2] + succinyl-CoA = CoA + N(6)-[(R)-S(8)- CC succinyldihydrolipoyl]-L-lysyl-[2-oxoglutarate dehydrogenase complex CC component E2]; Xref=Rhea:RHEA:15213, Rhea:RHEA-COMP:10581, Rhea:RHEA- CC COMP:10582, ChEBI:CHEBI:57287, ChEBI:CHEBI:57292, ChEBI:CHEBI:83100, CC ChEBI:CHEBI:83120; EC=2.3.1.61; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; CC -!- COFACTOR: CC Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937; CC Evidence={ECO:0000250}; CC -!- ACTIVITY REGULATION: Alpha-ketoglutarate dehydrogenase and CC decarboxylase activities are inhibited by unphosphorylated GarA, and CC allosterically activated by acetyl-CoA, the main substrate of the TCA CC cycle. {ECO:0000250}. CC -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; succinate CC from 2-oxoglutarate (transferase route): step 1/2. CC -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; succinyl- CC CoA from 2-oxoglutarate (dehydrogenase route): step 1/1. CC -!- SUBUNIT: Homodimer. The 2-oxoglutarate dehydrogenase (ODH) complex CC contains multiple copies of three enzymatic components: 2-oxoglutarate CC dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and CC lipoamide dehydrogenase (E3) (By similarity). {ECO:0000250}. CC -!- DOMAIN: Is a fusion protein with two major domains exhibiting CC structural features of an E1 and E2 protein, and a short sequence CC stretch of E1 localized at the N-terminus, which is connected by a CC linker region to the rest of the protein. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the 2-oxoacid dehydrogenase family. Kgd CC subfamily. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=CAC31476.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL583920; CAC31476.1; ALT_INIT; Genomic_DNA. DR PIR; A87046; A87046. DR RefSeq; NP_301802.2; NC_002677.1. DR RefSeq; WP_010908126.1; NC_002677.1. DR AlphaFoldDB; Q9CC97; -. DR SMR; Q9CC97; -. DR STRING; 272631.gene:17574921; -. DR KEGG; mle:ML1095; -. DR PATRIC; fig|272631.5.peg.1959; -. DR Leproma; ML1095; -. DR eggNOG; COG0508; Bacteria. DR eggNOG; COG0567; Bacteria. DR HOGENOM; CLU_004709_1_0_11; -. DR OrthoDB; 9759785at2; -. DR UniPathway; UPA00223; UER00997. DR UniPathway; UPA00223; UER01001. DR Proteomes; UP000000806; Chromosome. DR GO; GO:0050439; F:2-hydroxy-3-oxoadipate synthase activity; IEA:UniProtKB-EC. DR GO; GO:0008683; F:2-oxoglutarate decarboxylase activity; IEA:UniProtKB-EC. DR GO; GO:0004149; F:dihydrolipoyllysine-residue succinyltransferase activity; IEA:UniProtKB-EC. DR GO; GO:0000287; F:magnesium ion binding; IEA:UniProt. DR GO; GO:0004591; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; IEA:UniProtKB-EC. DR GO; GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro. DR GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-UniPathway. DR CDD; cd02016; TPP_E1_OGDC_like; 1. DR Gene3D; 3.40.50.12470; -; 1. DR Gene3D; 3.40.50.970; -; 1. DR Gene3D; 3.30.559.10; Chloramphenicol acetyltransferase-like domain; 1. DR Gene3D; 3.40.50.11610; Multifunctional 2-oxoglutarate metabolism enzyme, C-terminal domain; 1. DR Gene3D; 1.10.287.1150; TPP helical domain; 1. DR InterPro; IPR001078; 2-oxoacid_DH_actylTfrase. DR InterPro; IPR032106; 2-oxogl_dehyd_N. DR InterPro; IPR011603; 2oxoglutarate_DH_E1. DR InterPro; IPR023213; CAT-like_dom_sf. DR InterPro; IPR001017; DH_E1. DR InterPro; IPR031717; KGD_C. DR InterPro; IPR042179; KGD_C_sf. DR InterPro; IPR029061; THDP-binding. DR InterPro; IPR005475; Transketolase-like_Pyr-bd. DR NCBIfam; TIGR00239; 2oxo_dh_E1; 1. DR PANTHER; PTHR23152:SF4; 2-OXOADIPATE DEHYDROGENASE COMPLEX COMPONENT E1; 1. DR PANTHER; PTHR23152; 2-OXOGLUTARATE DEHYDROGENASE; 1. DR Pfam; PF00198; 2-oxoacid_dh; 1. DR Pfam; PF16078; 2-oxogl_dehyd_N; 1. DR Pfam; PF00676; E1_dh; 1. DR Pfam; PF16870; OxoGdeHyase_C; 1. DR Pfam; PF02779; Transket_pyr; 1. DR PIRSF; PIRSF000157; Oxoglu_dh_E1; 1. DR SMART; SM00861; Transket_pyr; 1. DR SUPFAM; SSF52777; CoA-dependent acyltransferases; 1. DR SUPFAM; SSF52518; Thiamin diphosphate-binding fold (THDP-binding); 2. PE 3: Inferred from homology; KW Acyltransferase; Allosteric enzyme; Coiled coil; Decarboxylase; Lyase; KW Magnesium; Metal-binding; Multifunctional enzyme; Oxidoreductase; KW Reference proteome; Thiamine pyrophosphate; Transferase; KW Tricarboxylic acid cycle. FT CHAIN 1..1238 FT /note="Multifunctional 2-oxoglutarate metabolism enzyme" FT /id="PRO_0000310716" FT REGION 1..41 FT /note="2-oxoglutarate dehydrogenase E1, N-terminal part" FT REGION 42..97 FT /note="Linker" FT REGION 44..108 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 98..346 FT /note="Succinyltransferase E2" FT REGION 347..1238 FT /note="2-oxoglutarate dehydrogenase E1, C-terminal part" FT COILED 795..825 FT /evidence="ECO:0000255" FT COMPBIAS 47..63 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 82..102 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 325 FT /note="Proton acceptor; for succinyltransferase activity" FT /evidence="ECO:0000250" FT BINDING 551 FT /ligand="thiamine diphosphate" FT /ligand_id="ChEBI:CHEBI:58937" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 590 FT /ligand="2-oxoglutarate" FT /ligand_id="ChEBI:CHEBI:16810" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 615 FT /ligand="2-oxoglutarate" FT /ligand_id="ChEBI:CHEBI:16810" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 615 FT /ligand="thiamine diphosphate" FT /ligand_id="ChEBI:CHEBI:58937" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 617 FT /ligand="thiamine diphosphate" FT /ligand_id="ChEBI:CHEBI:58937" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 657 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 657 FT /ligand="thiamine diphosphate" FT /ligand_id="ChEBI:CHEBI:58937" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 658 FT /ligand="thiamine diphosphate" FT /ligand_id="ChEBI:CHEBI:58937" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 659 FT /ligand="thiamine diphosphate" FT /ligand_id="ChEBI:CHEBI:58937" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 690 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 690 FT /ligand="thiamine diphosphate" FT /ligand_id="ChEBI:CHEBI:58937" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 692 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1032 FT /ligand="2-oxoglutarate" FT /ligand_id="ChEBI:CHEBI:16810" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1050 FT /ligand="acetyl-CoA" FT /ligand_id="ChEBI:CHEBI:57288" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1066 FT /ligand="acetyl-CoA" FT /ligand_id="ChEBI:CHEBI:57288" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1101 FT /ligand="acetyl-CoA" FT /ligand_id="ChEBI:CHEBI:57288" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1104 FT /ligand="acetyl-CoA" FT /ligand_id="ChEBI:CHEBI:57288" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1154 FT /ligand="acetyl-CoA" FT /ligand_id="ChEBI:CHEBI:57288" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1161 FT /ligand="acetyl-CoA" FT /ligand_id="ChEBI:CHEBI:57288" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" FT BINDING 1162 FT /ligand="acetyl-CoA" FT /ligand_id="ChEBI:CHEBI:57288" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:A0R2B1" SQ SEQUENCE 1238 AA; 137020 MW; 62B154E8A1D9A0E8 CRC64; MANISSPFGQ NEWLVEEMYR KFRDDPSSVD PSWHEFLVDY NPESTAEPVL TDPTSTDKQP SATPQAKPAA AADPVASRAK PATTPTVANG TAAGSAAAPA KTTTTPPIEG DELQVLRGAA AVVVKNMSAS LDVPTATSVR AVPAKLMIDN RTVINNQLKR NRGGKISFTH LLGYALVQAV KKFPNINRHY AEIDGKPIAV TPAHTNLGLA IDLQGKDGKR SLVVAGIKRC EELRFAQFVT AYEDIVRRAR DGKLTAEDFA GVTISLTNPG TIGTVHSVPR LMTGQGAIIG VGAMEYPAEF QGASAERIAE LGIGKLITLT STYDHRIIQG AESGDFLRTI HEMVLSDSFW DEIFRELSIP YLPVRWRTDN PDSIVDKNAR VMELIAAYRN RGHLMADIDP LRLDNTRFRS HPDLDLLTHG LTLWDLDRVF KVNGFGGWKY KKLRDVLGLL RDAYCRHIGV EYTHILDPEQ QEWLQQRVET KNVKPTVAEQ KYILSKLNAA EAFETFLHTK YVGQKRFSLE GAESVIPMMD AAIDQCAKHG LDEVVIGMPH RGRLNVLANI VGKPYSQIFT EFEGNLNPTL AHSSGDVKYH LGATGLYLQM FGDNDIQVSL TANPSHLEAV DPVLEGLVRA KQDLLNKDTN GNQDEAFSVV PMMLHGDAAF AGQGVVAETL NLANLPGYRV GGTIHIIVNN QIGFTTAPEY SRSSEYCTDV AKMIGAPIFH VNGDDPEACV WVAKLAVDFR QRFKKDVVID MLCYRRRGHN EGDDPSMTNP YMYDVVDTKR GARKSYTEAL IGRGDISLKE AEDALRDYQG QLERVFNEVR DLEKHGVQPS ESVESDQMIP AGLSTAVDKA LLARIGDAFL AVPEGFTVHP RVQPVLEKRR EMAYEGKIDW AFAELLALGS LVAEGKLVRL SGQDTKRGTF SQRHSVIIDR HTGEEFTPLQ LLANNPDGSP TGGKFLVYNS PLSEYAAVGF EYGYTVGNPD AVVLWEAQFG DFVNGAQSII DEFINSGEAK WGQLSTVVLL LPHGHEGQGP DHTSGRIERF LQLWAEGSMT FAVPSTPSNY FHLLRRHALD GIKRPLIVFT PKSMLRNKAA VSDIKDFTEI KFRSVLEEPT YEDSIDDRSK VTRVLLTCGK LYYELAARKI KDNRDDVAIV RIEQLAPLPR RRLGETLDRY ENAKEFFWVQ EEPANQGAWP RFGLELPELL PRLTGIKRIS RRAMSAPSSG SSKVHAVEQQ EILDTAFG //